U.S. Markets closed
  • S&P 500

    3,577.59
    +20.05 (+0.56%)
     
  • Dow 30

    29,591.27
    +327.79 (+1.12%)
     
  • Nasdaq

    11,880.63
    +25.66 (+0.22%)
     
  • Russell 2000

    1,818.30
    +32.96 (+1.85%)
     
  • Crude Oil

    43.03
    -0.03 (-0.07%)
     
  • Gold

    1,834.20
    -3.60 (-0.20%)
     
  • Silver

    23.59
    -0.04 (-0.18%)
     
  • EUR/USD

    1.1848
    -0.0014 (-0.1185%)
     
  • 10-Yr Bond

    0.8570
    +0.0280 (+3.38%)
     
  • Vix

    22.66
    -1.04 (-4.39%)
     
  • GBP/USD

    1.3332
    +0.0040 (+0.3040%)
     
  • USD/JPY

    104.4690
    +0.6410 (+0.6174%)
     
  • BTC-USD

    18,347.17
    -107.58 (-0.58%)
     
  • CMC Crypto 200

    365.78
    +4.35 (+1.20%)
     
  • FTSE 100

    6,333.84
    -17.61 (-0.28%)
     
  • Nikkei 225

    25,527.37
    -106.93 (-0.42%)
     

Acadia: 3Q Earnings Snapshot

·1 min read

SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Wednesday reported a loss of $84.7 million in its third quarter.

The San Diego-based company said it had a loss of 54 cents per share.

The results did not meet Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 38 cents per share.

The drugmaker posted revenue of $120.6 million in the period, which topped Street forecasts. Seven analysts surveyed by Zacks expected $118.8 million.

Acadia shares have risen 15% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $49.13, an increase of 16% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACAD at https://www.zacks.com/ap/ACAD